A variety of post-translational modifications and aggregation of tau and the presence of PHFs and NFTs inside neurons or glial cells (astrocytes and oligodendrocytes) is the pathological hallmark of AD and related tauopathies (Lee et al., 2001). This evidence concerns the gene MAPT and Alzheimer disease.